Susquehanna International Group’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$367K Buy
502,300
+426,170
+560% +$1.94M ﹤0.01% 10419
2025
Q4
$426K Buy
76,130
+74,415
+4,339% +$828K ﹤0.01% 9166
2025
Q3
$12.7K Sell
1,715
-17,040
-91% -$145K ﹤0.01% 12085
2025
Q2
$143K Sell
18,755
-220
-1% -$3.43K ﹤0.01% 11536
2025
Q1
$361K Buy
18,975
+11,260
+146% +$354K ﹤0.01% 9652
2024
Q4
$279K Buy
7,715
+4,075
+112% +$113K ﹤0.01% 9985
2024
Q3
$105K Sell
3,640
-2,625
-42% -$58.3K ﹤0.01% 11033
2024
Q2
$160K Sell
6,265
-3,895
-38% -$177K ﹤0.01% 10622
2024
Q1
$768K Buy
10,160
+1,160
+13% +$91.9K ﹤0.01% 7498
2023
Q4
$927K Sell
9,000
-12,030
-57% -$1.08M ﹤0.01% 7164
2023
Q3
$2.05M Sell
21,030
-14,905
-41% -$1.39M ﹤0.01% 5079
2023
Q2
$4.21M Buy
35,935
+31,850
+780% +$4.04M ﹤0.01% 3802
2023
Q1
$342K Sell
4,085
-3,110
-43% -$272K ﹤0.01% 9442
2022
Q4
$612K Sell
7,195
-2,160
-23% -$165K ﹤0.01% 7338
2022
Q3
$297K Sell
9,355
-3,025
-24% -$83.6K ﹤0.01% 9820
2022
Q2
$272K Buy
12,380
+9,940
+407% +$348K ﹤0.01% 9831
2022
Q1
$120K Buy
+2,440
New +$97.4K ﹤0.01% 11768

Other funds holding RVPH

Susquehanna International Group's RVPH Position: Q1 2026 in Review

Susquehanna International Group sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q1 2026, closing a stake of 34,103 shares — an estimated $155K sold.

Susquehanna International Group first reported a position in RVPH in Q3 2021 and held it in 15 quarters. The position peaked at $1.06M in Q4 2023. 35 funds tracked by Wall St. Rank hold RVPH as of Q1 2026.

  • Susquehanna International Group reported no remaining REVIVA PHARMA HLDGS INC position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 34,103 REVIVA PHARMA HLDGS INC shares in Q1 2026, an estimated $155K.
  • Susquehanna International Group first reported a position in REVIVA PHARMA HLDGS INC in Q3 2021 and held it in 15 quarters.
  • Susquehanna International Group's REVIVA PHARMA HLDGS INC position peaked at $1.06M in Q4 2023.
  • 35 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.